News & Analysis on Clinical Trial Services & Contract Research And Development
Elchrom Scientific introduces a novel purification technology enabling a greater yield of ultra pure siRNA synthetic oligonucleotides at a faster turn around rate, rapidly increasing siRNA oligonucleotides (oligos) quantity required in medical, drug...
Pipetting technology company CyBio has posted half year sales of €4.5m, down slightly on the €4.6m in 2003. This muted sales performance is attributed to the differing development of business in CyBio's sales regions.
Imaging Systems Company, Richardson Technologies, are to showcase its Real Time Microscope (RTM), a radical imaging system capable of providing real time, full colour images, providing improved sample detail, essential for pharmaceutical research.
Netherlands-based Qiagen achieved organic growth of 32 per cent for the second quarter of 2004, but profits fell by a fifth as the cost of restructuring took its toll.
Researchers at Newcastle's Centre for Life have been given the go-ahead to create stem cells from unfertilised human eggs, thought to be the first time that such a license has been granted in Europe.
The first ever application to start clinical trials of a therapeutic based on small interfering RNA (siRNA) - for the wet form of the eye disease age-related macular degeneration - has been filed by Acuity Pharmaceuticals.